AACR Annual Meeting 2019: New Approaches to Treating Drug-resistant Non-small Cell Lung Cancer
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
Category: AACR
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
The AACR-Bayer Innovation and Discovery Grants program supports researchers who are seeking to develop new treatment options for cancers...
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
Persistent infections from pathogens are a major cause of cancer incidence worldwide. An analysis from 2012 indicates that more...
Recent advances in cancer research has led to enormous progress against many cancer types. From 1991 to 2015, we...
Cancer prevention refers to measures that people can take to reduce their risk of developing cancer. These measures can...
The spectacular sight of the AACR Annual Meeting 2019 Opening Ceremony, held Sunday, March 31, at the Georgia World...
Like many Americans, Dr. Jill Biden has been personally affected by cancer. Friends, her parents, and her son Beau...
Two of the nation’s preeminent leaders in cancer research and policy took the stage Sunday morning at the Opening...